Subject: Smallcap Discoveries: Weekly Update: December 19 - 30

December 19 - 30

Market Commentary

Buys and Sells This Week

Markets

2022 has come to an end, and many investors are happy to see the year in the rear-view mirror. The DOW ended 2022 down 8.8% while Nasdaq was down 33.1% and the TSX actually performed the best, being down 8.5%. It’s been a year of heavy rotation. Value stocks performed better than growth stocks and many once high-flying popular company stocks were taken to the woodshed.


2022 was a year of outperformance of the “boring” businesses. Sexy, money losing businesses were out and boring, money-making businesses were in.

Big tech was a big loser in 2022. Names such as Apple (AAPL) -25.5%, Microsoft (MSFT) -27.3% doing considerably better than Amazon (AMZN) -50.6%, Advanced Micro Devices (AMD) -53.3%, or mega losers like Tesla (TSLA) -60.6% and Meta (META) -64.4%.

The best performing sectors in 2022, by ETF’s, were VanEck Vectors Oil Services ETF (OIH)FlexShares Morningstar Global Upstream Natural Resources Index Fund (GUNR), VanEck Vectors Steel ETF (SLX), iShares U.S. Insurance ETF (IAK) and iShares U.S. Aerospace & Defense ETF (ITA).


Energy was an obvious winner with energy services outperforming energy producers. This was a theme that we caught relatively early in the year and helped drive one of our biggest winners Bri-Chem (BRY.T) to a 267% return on the year.


2022 was also the year of the return of rapid inflation and in response most central banks raised rates at the fastest pace in history. Broken global supply chains were a big cause as was the war in Ukraine and its effect on energy and food supplies. Moving important goods around the world continued to be challenging, and freight rates reached historically high levels but in recent months these rates have dropped off rapidly to near pre-pandemic levels.

With many goods and services still priced well above pre-pandemic levels central bankers are maintaining tighter monetary policy and are expected to continue raising rates albeit slower than in the past 6 months. Labor, especially North American labor markets, continues to be stronger than many were predicting and likely prolong a tightening bias and push off an expected recession. It appears that the stronger labor market is a result of increased deglobalization and the continued on-shoring of critical manufacturing and services. This was another theme that we picked up early in the year and continues to benefit a number of companies in our portfolio. One big winner was Inventronics (IVX.V) which gained 61% and delivered another $0.35 (17%) in special dividend.


This on-shoring trend is one that we believe has a long runway. Not only does this trend look healthy but many companies that will be positively affected by this shift continue to trade at near historically low valuation metrics, with the nano-caps in the space trading even cheaper.


Inflation is slowing. Money supply has been dropping. The economy will slow. The US Money Supply has fallen 1.7% over the last 8 months, the largest decline over an 8-month period on record (note: M2 data goes back to 1959).

A recession seems likely. Inflation will continue to slow down. Labor will weaken in a slowing economy brought on by higher interest rates. Interest rates are likely to stay higher for longer. And we may never, in our lifetimes, see interest rates at the low levels we have seen in the recent past.


These are all factors that are affecting investor’s actions. Many investors are fearful and don’t know what to do. In response, many are selling stocks and moving to cash. Investors just pulled out a record $42 billion from stocks in one week.


Be greedy when others are fearful and fearful when others are greedy – Warren Buffett


Investors fled the equity markets at a record pace in 2022.

The question for equity investors is whether stocks are accurately priced for coming economic events? 


There is plenty of cash on the sidelines which is one of the key necessities for the start of a new bull market. Many stocks, especially those that have been out of favor for many years, are trading at very cheap levels and offer great risk/reward opportunities for savvy investors that have long-term investing strategies and that can be greedy while others are fearful.


Energy

In 2022, oil prices went on a roller coaster ride. WTI oil started the year at around the US$75 level and ended the year at roughly $80, an increase of about 7%, yet it was anything but a straight line.

WTI oil spiked in March to $130 per barrel in the early days of the Ukraine conflict and remained volatile running back up above $120 in June before starting a long downtrend down to levels last seen before the Russian invasion of Ukraine.


There are so many moving parts when it comes to oil that it’s impossible to predict where oil is going in the short term; however a dramatic lack of industry investment can help us determine where it’s going in the longer term. While there has been a nice pickup in energy exploration and development, the results of this pickup in investment are not dramatically changing the amount of oil and gas that is being produced. This is another one of the charts that makes me maintain a bullish stance on energy service companies.

However, over the last 3 months of the year, energy service companies have begun to significantly outperform energy producers.

In my opinion, national energy security will trump energy price concerns. Where oil comes from will matter more. With the need to refill the US strategic petroleum reserve and limited friendly countries around the world willing to help re-stock this the importance of North American reserves and production will become paramount. North American energy producers have squeezed almost every drop out of their existing wells and will need to focus more on new production if they are to maintain cash flows. I believe there will be less emphasis on share buybacks and dividends and more on maintaining production levels and/or growth. They will have to drill.


And I think there is lots that even non-energy investors can learn from what we have seen in the energy sector. Energy stocks were shunned by investors for many years. The significant lack of investment has set up a major up cycle that should last for many years. Under-investment leads to low supply and when demand increases the supply/demand imbalance leads to higher prices and profits. There are many other sectors that could see similar outcomes. I could see it happening with industrials, commodities, and even housing at some point if we see a sharp drop-off in home building.


Baker Hughes drilling data – Canadian drilling activity saw a sharp drop off the past few weeks as is normal for this time of year as most will shut down for the Christmas holiday season. We will see a sharp increase in the first few weeks of January.


Commodities

2022 was the year of the US dollar. How often have we heard of the impending decline of the US greenback? Most major commodities are priced in US dollars and the impact of a higher US dollar was obvious on many commodities.

The US dollar peaked in September and since then, most major commodities have stabilized and/or started trending higher. It’s no coincidence that the precious metals hit their year lows right around the time the DXY hit its peak.

Industrial metals such as copper and zinc will parallel global industrial activity and with global economic slowdown, especially in China, most major industrial metals were lower in 2022 and likely will continue that way until there are signs of a pickup in global economic activity. But as we saw with energy, the years of under-investment in mineral exploration could be the perfect set up for a major bull market in industrial metals when the world economy gets going again.

Mining service companies like Geodrill (GEO.T) and Foraco (FAR.T) should be well positioned for the next bull move in metal commodities.


Stocks

It felt like 2022 was a year when fundamentals started to matter again. Companies that generated real profits and cash flow were of interest again to investors. Growth at all costs without profits and with no regard to valuations was discarded like a pair of old soulless shoes.


Boring was beautiful.


Old school industrials were beautiful again. North American manufacturers trading at single digit PE ratios were sexy (at least to me, they were).


How many times did you hear us talk about double digit growers trading at single digit PE ratios?


While many of these types of companies did quite well, so many of them still trade at historically low valuations and continue to grow. I believe it’s because the majority of investors still have not come to grips with the sea change in the investing landscape. Higher interest rates for longer, on-shoring and many years of low re-investment and capital spending on manufacturing infrastructure doesn’t change industry over night and certainly, investor sentiment to it doesn’t change very quickly.


One of my major themes for 2023 and beyond will be the rebuilding of the North American manufacturing base that for the past 20 plus years has been decimated by globalization. If you could pick one location to locate a manufacturing facility today, where would that be? Consider the needs for cheap and reliable energy, a skilled and stable labor force, stable political environment, access to a safe supply of needed resources, stable currency, stable supply chain, and close and easy/cheap access to major demand?


We talk to many management teams, and it’s become obvious that securing stable supply of critical materials and components has become a major company directive. Security of supply, whether that be computer chips, energy, natural resources or even labor is a new mantra for both governments and businesses and as we advance more towards automation, secure supply of cheap labor is likely to become less important. Here’s an interesting video on this very subject https://www.youtube.com/watch?v=o6pCZFCywao


Valuations will matter again in 2023. It’s hard to imagine that valuations were ever important but with near free money for so long you can understand why investors didn’t need to see companies generate profit if these companies could just go and get capital at almost zero cost and raising money through equity raises was easy too because there was no competition from debt as everyone was looking for any kind of yield even if it was zero, lol.


Having cash on the balance sheet was considered a no-no. Cash was trash because it wasn’t being used to grow revenues or to acquire revenues. We have done a complete 180. Cash is king now because cash is hard to come by.  Yes, investor cash might be on the sidelines, but investors are holding in tightly in their clenched fists, and they now have alternatives to no/low yielding equities. Cash in the bank actually offers a return now.


Capital light businesses, the holy grail for so many investors for the past decade plus are now being shunned due to high valuations and lack of immediate cash returns. Capital intensive businesses with an established footprint, which one would think is counter-intuitive in the current marketplace, are getting some love for a change. That’s because the replacement costs for these facilities now are sky-high. To build a new capital-intensive business would be very costly and time-consuming meaning that existing facilities should have increased demand for the near future and have pricing power while competitors scramble to increase supply capacity. It lends itself to an environment of buying existing operations vs building new. It’s another reason why we believe there will be an increase in mergers and acquisitions in a range of different manufacturing industries, especially in North America.


I think 2023 will be the year of the smaller company. Massive amounts of capital have gone into passive investing strategies that was just funneled into large liquid stocks because they were large and liquid. It will be easier for many of these big companies to grow through acquisitions of smaller, cheaper companies than it will be to build revenue organically for the reasons I stated in the last paragraph. Small companies are better positioned to be able to take advantage of changes in industry, pivot if necessary and many already dominate niches that are less effected by a slowing economy. Small companies that are self generating cash will also be in a position to take advantage of opportunities down market that may be too small for bigger companies. Maybe roll up niches or reinvest where new competitors can’t. And remember so many of these small companies have been ignored for so long that they are still cheap and have little competition because of the lack of investment into other small companies in their field.


And lastly, I think 2023 will be the year of the stock picker. The other major sea change I see coming is the move away from passive investing, index investing and large stocks. For the past 20+ years the move towards passive investing has been a major driver of returns and PE expansion in big stocks. Valuations in big stocks dwarfed valuations in small stocks. This has been a historic anomaly. Smaller, faster growing companies used to trade at premiums to their slower moving comps. I think we will see this reverse over time and get back to historic norms where smaller, faster growing companies trade at premiums to big stocks. It will be important to find companies that are not just momentum plays, like in the past, but have real fundamental reasons for investors to want to own them, not just fear of missing out (FOMO) or big capitals need for buying liquidity.   


So, to summarize, I’ll continue to look for small, established and growing companies that operate in capital intensive industries with an established presence in North America and, in many ways, the more boring the business the better. Growth will be important and low valuations will be extremely important. Not only will cash be king, but CASH FLOW will be the king of kings!


It would not surprise me to see further downside on the major market indexes. If this continues to happen, I suspect we will see more mispricing in the micro-caps and nano-caps and potential for better buying opportunities as investors continue to flee to the sidelines and throw the babies out with the bath water. This would set us up for I would call GASP investing, growth at a stupid price. We saw plenty of that in 2022 and no reason to believe we won’t see more of it in 2023.


Other Stuff

I thought it would make sense to talk a bit about my largest holding and some of the stocks we spent a lot of time talking about this past year, a recap of some of the highlights and what I expect in 2023. We can cover more of them by request in our next few free-for-all's.

I’ll start with my largest holding, ImmunoPrecise Antibodies (IPA) (US$5.21) (-2.8%). 2022 was a somewhat uneventful year for the share price of the company but in my opinion, was a year of building for what should be a very pivotal year in 2023. In 2022 the company:


I expect we will see their Covid-19 polytope therapeutic enter clinical trials in the first quarter of 2023. This will establish the company as a clinical stage biotech and hopefully on success should lead towards a partnership to push this therapeutic forward to commercialization, where there are now no approved antibody therapeutics.

I’m also expecting more validation of the Biostrand AI offerings through both results from their Briacell partnership and announcements of new Biostrand partnerships with small and large pharma partners.


And lastly, I expect we will hear more news on the Talem pipeline of drug candidates with several possible biobuck opportunities in discussions.


At this time, I’m taking a wait and see approach. I’m personally well positioned and will wait for either a revenue inflection higher (not expected yet) or a major partnership announcement that gives me a better indication of future value. I view the stock as a hold at current levels.

My second-largest holding is NameSilo Technologies (URL.C) $0.165) (0.0%). For full disclosure, I am the CEO and a director of the company. The stock was flat for the year and closed 2022 right where it did at the end of 2021. In 2022, the company:



I expect more of the same in 2023 as we saw in 2022. Focus will be on developing and launching new products and services, growing gross margins and allocating free cash flow to both the NCIB and new investment opportunities.

My third-largest position is Atlas Engineered Products (AEP.V) (+25.0%). For full disclosure, I am a director of the company. In 2022, shares in the company were higher by 25% and the company:



The company was able to successfully integrate their latest acquisition and saw continued revenue and earnings growth despite lower pass-through lumber prices. Higher interest rates are expected to effect Canadian housing starts in the shorter term but longer term growth in demand for housing units due to population growth and increased immigration should bolster demand within the industry. Here’s another interesting article on Canadian immigration policy and potential effect on housing and industry: Canadian approach to immigration seems much smarter than ours.

Coming in at number 4 for me is Ceapro (CZO.V) ($0.59) (-3.3%). Another stock that barely moved from its 2021 closing price, although it was a record year in terms of financial results, and it moved several projects forward which I believe has de-risked the opportunity further. In 2022, Ceapro:


 

For a company that accomplished what it did in 2022, you’d think its shares would have fared better. The stock closed the year with a trailing TTM PE of 8.7 and a trailing EV/E of only 6.3 times. Hard to imagine any biotech trading with these kinds of numbers, but that’s the opportunity that presents itself right now. It’s probably my biggest table pounding buy at the moment, and I will likely be adding to my position if it continues to trade at these levels in the new year.

Number 5 is a relatively newer name, Zedcor Inc. (ZDC.V) ($0.60) (+46.3%). The stock closed very near its 52-week high and up nicely since we first highlighted it in early November. In 2022, the company:



I’m impressed with Zedcor’s financial performance. It’s the type of company that could compound its growth consistently provided it can continue to fund its capital equipment requirements. The stock has gone near parabolic since November and I feel it needs to consolidate its recent gains. This is another one I like a lot but will wait for drop in share price, or some time to consolidate the recent move. I’d like to add to my position ideally in the low 50’s but will monitor it closely over the next month or so. This one has very good long-term potential in my opinion.

Bri-Chem Corp. (BRY-T) ($0.66) (+312.5%) was one of my big winners in 2022. Having started a position in the low $0.20 level, the stock rallied to a high of $0.95 and settled the year at $0.66. Oil and gas service companies were hot, and I believe will continue to do well in 2023. In 2020 the company:


The company has substantially improved its balance sheet which was one of big concerns when we first highlighted the company. Improving industry fundamentals and a more bullish sentiment towards the sector should further push the fundamentals and stock higher. I’m looking to add on dips.

Next up is BeWhere Holdings (BEW.V) ($0.225) (-13.5%). BeWhere continued to grow its revenues and earnings in 2022. It’s been a consistent grower, but I feel it hasn’t garnered mainstream attention….yet. In 2022, the company:



Compared to some of the other companies we are finding BEW is not super cheap. But the consistency of its revenue growth and the scalability of its business model makes this one a longer-term favorite of mine. I think the share price could be relatively flat for the near future, but it’s one I’m happy to hold and will look for a reason to add down the road. I view it as a strong hold for now.

Another one of my current favorites and a solid performer this past year is Inventronics (IVX.V) ($3.50) (+58.4%). This one fits most of the criteria I talked about earlier. In 2022, the company:


Trading at a trailing 12-month PE of only 6.8 times, this one continues to look like a no-brainer to me. It has been a Cheapies with a Chance favorite for a few years and still ranks very well even after the big price move. I think the special dividend may shrink but likely become a much more regular event. I’m a buyer on dips.

And last on the list is another long time Cheapies with a Chance list company, IBEX Technologies (IBT.V) ($0.80) (+56.9%). IBT turned out to be a very pleasant surprise with the shares hitting new multi-year highs. We highlighted it on numerous occasions as a great buy out candidate and the recent price movement makes me think that someone else agrees with us. In 2022, the company:



While the stock still looks cheap, the recent 67% spike in share price over the last 3 weeks has us thinking the stock needs to cool off a bit. I’ve sold a little bit into this spike and will look to add it back on any meaningful pullback. Until then, I think this is a hold or sell for some of the short-term traders. But it wouldn’t surprise me if this recent spike is due to someone looking to swallow it up.

The stock that I don’t own that has me the most intrigued is Crescita Therapeutics (CTX.V). Very low EV, somewhat profitable (lumpy) and a pipeline of revenue-generating products and services. I love the risk-reward here. Plenty of cash and plenty of “NEW” stuff that could add good upside. Stock is relatively unknown and hard to understand. NCIB. There is no way you could replace this business for the EV.

Thinking points for 2023….


I like buying growing businesses that appear misunderstood, mispriced, cheap. I find that more often in small names, and it seems the smaller, the better. Low liquidity doesn’t matter to me. Liquidity always seems to come with higher prices. Focus less on liquidity and more on being right.


I like boring businesses; it keeps stock junkies away until the stock gets sexy. Boring businesses that grow often turn into sexy stocks.


Low valuations/prices are always the best insurance.


The days are long, but the years are short. Buy businesses you intend on owning for a long time and focus less on short term price movements.


Let’s keep it simple: we want to own cheap stocks that are growing. Small is cheap right now and boring is cheap. Some cyclicals look cheap too, but often they look cheap just as the cycle is ready to turn lower, so we need to have a high margin of safety priced in.


Other, other stuff

We just finished our Cheapies with a Chance list for 2022, and you should receive it very shortly so keep an eye out for it. We have a few new names and a few old favorites that popped up again.

 

I want to thank everyone who helped me reach my goal of 14,000 twitter followers before year-end and as promised, I’ve donated $5000 to my favorite charity the West Coast Kids Cancer Foundation. They do some great work and I hope you consider donating to help them continue to do what they do.


And lastly, I want to thank all SCD members for your continued interest in what we do. I’m humbled and proud of the community we’ve built. Trevor and I will continue to try and find new ideas and new ways that we can make your investing journey more successful and enjoyable. On behalf of Trevor and the rest of the SCD team, I want to wish everyone a healthy and happy new year.


To your wealth,

Paul and Trevor

Sold (partial profits) Zedcor, (ZDC.V) @ $0.60

Sold (partial profits) Bri-Chem (BRY.T) @ $0.72

Sold (partial profits) IBEX Technologies (IBT.V) @ $0.77

Smallcap Discoveries


Select Portfolio

Ceapro (TSX.V: CZO) Price - $0.63 Market Cap - $49M


RIWI Corp (TSX.V: RIWI) Price - $0.59 Market Cap - $10.5M


iFabric (TSX.V: IFA) Price - $0.77 Market Cap - $23M


Spectra Products (TSX.V: SSA) Price - $0.175 Market Cap - $2.5M


Vitality Products (TSX.V: VPI) Price - $0.05 Market Cap - $2M

Smallcap Discoveries


Select Watchlist

Aequus Pharmaceuticals (TSX.V: AQS) Price - $0.035 Market Cap - $4.5M


Boardwalktech Software (TSX.V: BWLK) Price - $0.79 Market Cap - $35.5M


Bri-Chem (TSX: BRY) Price - $0.69 Market Cap - $18M


Cematrix (TSX.V: CVX) Price - $0.22 Market Cap - $29.5M


Gatekeeper Systems (TSX.V: GSI) Price - $0.265 Market Cap - $24M

  • Reports FY Financials

  • FY Revenue of $20M

  • FY Gross profit of $9.3M

  • FY Net income of $1.92M

  • Q4 Revenue of $10M

  • Q4 Net income of $2.7M


Nuvo Pharmaceuticals (TSX.V: MRV) Price - $0.67 Market Cap - $7.6M


Terra Firma Capital (TSX.V: TII) Price - $5.35 Market Cap - $30M


CanadaBis Capital(TSX.V: CANB) Price - $0.08 Market Cap - $11M


Firan Technology (TSX: FTG) Price - $2.35 Market Cap - $58M


Prodigy Ventures (TSX.V: PGV) Price - $0.035 Market Cap - $5M


Company Interviews & Updates

Upcoming

Topic: Firan Technology (TSX: FTG) Update with CEO Brad Bourne

Time: Jan 3, 2023 01:15 PM Vancouver


Join Zoom Meeting

https://us02web.zoom.us/j/87922204037?pwd=MW9FVXB3SmpBUGlDcllHMlFmMUorZz09


Meeting ID: 879 2220 4037

Passcode: 812013


Topic: Biorem (TSX.V: BRM) Update with CEO Derek Webb

Time: Jan 4, 2023 01:15 PM Vancouver


Join Zoom Meeting

https://us02web.zoom.us/j/81907745708?pwd=OEpUU3ZKcjBiYXo0RjI3c2JXcUNoUT09


Meeting ID: 819 0774 5708

Passcode: 892395


Topic: POSaBIT (TSX.V: PBIT)

Time: Jan 5, 2023 01:15 PM Vancouver


Join Zoom Meeting

https://us02web.zoom.us/j/81453494698?pwd=d1BjenMrSVc3dlhublRIQTBMaEF5Zz09


Meeting ID: 814 5349 4698

Passcode: 826541

Recent

If you missed the last email, or need access to any Smallcap Discoveries tools, be sure to check out the website

Don't forget to follow us on social media!

We support the West Coast Kids Cancer Foundation


https://www.wckfoundation.ca/


Powered by:
GetResponse